ClinicalTrials.Veeva

Menu

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

University of Illinois logo

University of Illinois

Status

Completed

Conditions

Subarachnoid Hemorrhage
Intracerebral Hemorrhage

Treatments

Drug: Nicardipine and Nipride

Study type

Observational

Funder types

Other

Identifiers

NCT00490464
2004-0233

Details and patient eligibility

About

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Enrollment

163 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-70 years old (inclusive)
  • Admission to NSICU with a diagnosis of SAH or ICH

Exclusion criteria

  • Patients who are admitted >48 hours after SAH or ICH
  • Readmission or second SAH
  • Readmission or second ICH
  • Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
  • Women who are pregnant

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems